Ipamorelin 10 mg Certificate of Analysis Batch APL-IPA10-2607-02

Ipamorelin 10 mg from batch APL-IPA10-2607-02 was analysed on 17 July 2026 and measured 99.26% purity by HPLC / Mass Spectrometry, passing all 5 release tests.

Purity: 99.26%
Result: All 5 tests passed
Tested: 17 July 2026
Method: HPLC / Mass Spectrometry
Net content: 10.12 mg

Independent verification

Ipamorelin 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 99.22% purity by UPLC-MS/MS, analysed 28 August 2026 on lot APL-IPA10-2608-01, net content 9.83 mg, verification code OZ-HPLCMS-TS03; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 28 August 2026, verification code OZ-ENDOTX-TPA6.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Third-Party Purity COA (PDF, opens in a new tab)99.22% purity by UPLC-MS/MS · net content 9.83 mg Analysed 28 August 2026 Verification code OZ-HPLCMS-TS03
Third-Party Endotoxin Test (PDF, opens in a new tab)Bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL Analysed 28 August 2026 Verification code OZ-ENDOTX-TPA6

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 2

Certificate of Analysis Ipamorelin 10 mg Batch APL-IPA10-2607-02

Compound: Ipamorelin
Lot Number: APL-IPA10-2607-02
Analysis Date: 17 July 2026
Method: HPLC / Mass Spectrometry
Purity: 99.26%
Net Content: 10.12 mg

CAS Number: 170851-70-4
Formula: C38H49N9O5
Molecular Weight: 711.85 g/mol
Form: Lyophilised Powder
Manufactured: July 2026
Issued: 18 July 2026
Document ID: APL-COA-IPA10-2607-02
Verification Code: Batch traceable

SequenceAib-His-D-2-Nal-D-Phe-Lys-NH2

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

Main peak integrated at 99.26% of total area; no single impurity peak exceeds 0.21%.

Peak List

Peaks detected: 5

#	Time (min)	Area	% Area	Identification
1	3.350	12,382	0.200	—
2	3.634	6,225,647	99.260	Ipamorelin
3	3.835	13,029	0.210	—
4	4.273	12,015	0.190	—
5	5.401	8,790	0.140	—

Analytical Results

Test	Specification	Result	Status
Appearance	White/Off-White Lyophilised Powder	Conforms	PASS
Identity (MS)	Confirmed	Confirmed	PASS
Purity (HPLC)	≥98.0%	99.26%	PASS
Peptide Content	95–105%	98.0%	PASS
Endotoxins	<0.5 EU/mg	<0.15 EU/mg	PASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 2

Ipamorelin 10 mg

CAS Number: 170851-70-4

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 17 July 2026

Monitored (m/z)	Detected (m/z)	Relative Intensity
357	356.96	1.5
713	712.84	1.98

Detection assignment: Ipamorelin

Collected Mass Spectrum

Intensity ×10⁷

Verification Protocol

Identity confirmed by mass spectrometry against the expected ion channels.
Purity measured by HPLC as peak area against all integrated impurity peaks.
Batch traceability: this document reports the lot number printed on the vial.
Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View Ipamorelin in the catalogue How to read this certificate